title: A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.
authors.affiliation: Department of Haematology, University College Hospital, University College Hospitals NHS Trust, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Kothari
authors.affiliation: Department of Haematology, University College Hospital, University College Hospitals NHS Trust, London, UK.
authors.forename: M
authors.initials: M
authors.lastname: Foley
authors.affiliation: UCL Cancer Institute, University College London, London, UK.
authors.forename: K S
authors.initials: KS
authors.lastname: Peggs
authors.affiliation: Department of Haematology, University College Hospital, University College Hospitals NHS Trust, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Mackenzie
authors.affiliation: Department of Haematology, University College Hospital, University College Hospitals NHS Trust, London, UK.
authors.forename: K
authors.initials: K
authors.lastname: Thomson
authors.affiliation: Department of Immunology, University College London, London, UK.
authors.forename: E
authors.initials: E
authors.lastname: Morris
authors.affiliation: Department of Haematology, University College Hospital, University College Hospitals NHS Trust, London, UK.
authors.forename: K M
authors.initials: KM
authors.lastname: Ardeshna
authors.affiliation: Department of Haematology, University College Hospital, University College Hospitals NHS Trust, London, UK.
authors.forename: A E
authors.initials: AE
authors.lastname: Virchis
authors.affiliation: UCL Cancer Institute, University College London, London, UK.
authors.forename: D C
authors.initials: DC
authors.lastname: Linch
authors.affiliation: Department of Haematology, University College Hospital, University College Hospitals NHS Trust, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Lambert
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods / Q000401:mortality; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use; D008223:Lymphoma / Q000401:mortality / Q000628:therapy*; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D016879:Salvage Therapy / Q000379:methods; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000379:methods* / Q000401:mortality / Q000592:standards; D014182:Transplantation, Autologous
chemical_list: D003561:Cytarabine; D005047:Etoposide; D008130:Lomustine; D008558:Melphalan; D002330:Carmustine